CH/HDVCH/Versiti Quality Metrics Meeting Series 2026

Occurs every 3 months on the 2nd Thursday starting on 2/12/2026 at 12:00 PM
Thursday, February 12, 2026, 12:00 PM - 1:00 PM, Online


AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours)

Presentations will be provided by Adult and Pediatric Quality Managers, Data Managers, Infection Prevention specialists, Versiti MI representatives, and BMT staff engaged in quality improvement initiatives. The data and analysis will cover: Patient experience metrics Transplant and collection volumes Neutrophil and platelet engraftment timelines IEC and DLI outcomes Length of stay and readmission rates Morbidity and mortality trends Acute and chronic GVHD incidence Deviations and error tracking Opportunities for improvement and areas requiring further investigation will be identified throughout the review.

1. Gain a clear understanding of the BMT program’s performance and quality outcomes.
2. Identify opportunities for deeper analysis and targeted improvement initiatives.
3. Determine practice changes necessary to enhance quality and improve survival outcomes.

Corewell Health West Michigan is accredited by the Michigan State Medical Society to provide continuing medical education for physicians.

Corewell Health West Michigan designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Corewell Health West Michigan adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Corewell Health West Michigan adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.